We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,562

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBCP icon
12876
PUT
Concrete Pumping Holdings
BBCP
$484M
$15.3K ﹤0.01%
+1,900
New +$13.4K
ENLV icon
12877
CALL
Enlivex Ltd
ENLV
$26.6M
$15.3K ﹤0.01%
387
-373
-49% -$15.6K
NMTR
12878
CALL
DELISTED
9 Meters Biopharma
NMTR
$15.3K ﹤0.01%
22,700
-3,200
-12% -$2.83K
CTMX icon
12879
CytomX Therapeutics
CTMX
$732M
$15.2K ﹤0.01%
8,854
-269,823
-97% -$448K
NMG
12880
PUT
Nouveau Monde Graphite
NMG
$484M
$15.2K ﹤0.01%
5,000
-15,400
-75% -$56.5K
VGZ icon
12881
CALL
Vista Gold
VGZ
$337M
$15.2K ﹤0.01%
+29,200
New +$17.8K
KRMD icon
12882
CALL
KORU Medical Systems
KRMD
$157M
$15.2K ﹤0.01%
4,400
+2,200
+100% +$8.64K
IEV icon
12883
PUT
iShares Europe ETF
IEV
$1.7B
$15.2K ﹤0.01%
300
-800
-73% -$40.7K
STGW icon
12884
CALL
Stagwell
STGW
$2.23B
$15.1K ﹤0.01%
+2,100
New +$13.9K
CSTL icon
12885
PUT
Castle Biosciences
CSTL
$905M
$15.1K ﹤0.01%
1,100
+900
+450% +$18.2K
ACT icon
12886
PUT
Enact Holdings
ACT
$6.87B
$15.1K ﹤0.01%
600
-800
-57% -$19.5K
BKCH icon
12887
Global X Blockchain ETF
BKCH
$205M
$15.1K ﹤0.01%
488
-9,890
-95% -$243K
BYRN icon
12888
PUT
Byrna Technologies
BYRN
$95.5M
$15K ﹤0.01%
3,000
+2,400
+400% +$13K
NKTR icon
12889
CALL
Nektar Therapeutics
NKTR
$2.49B
$15K ﹤0.01%
1,740
-4,347
-71% -$46.4K
CARS icon
12890
Cars.com
CARS
$663M
$15K ﹤0.01%
757
-448
-37% -$8.43K
SLGL icon
12891
PUT
Sol-Gel Technologies
SLGL
$277M
$15K ﹤0.01%
+500
New +$17.5K
XNCR icon
12892
PUT
Xencor
XNCR
$1.74B
$15K ﹤0.01%
600
-3,300
-85% -$89.8K
BLIN icon
12893
Bridgeline Digital
BLIN
$12.6M
$15K ﹤0.01%
12,690
-19,056
-60% -$19.1K
SBFMW
12894
Sunshine Biopharma Inc Warrant
SBFMW
$131K
$15K ﹤0.01%
+31,148
New +$14K
EHAB
12895
PUT
DELISTED
Enhabit
EHAB
$14.9K ﹤0.01%
1,300
+200
+18% +$2.5K
CMCM
12896
CALL
Cheetah Mobile
CMCM
$103M
$14.9K ﹤0.01%
6,400
+4,500
+237% +$10.2K
CNTY icon
12897
PUT
Century Casinos
CNTY
$36M
$14.9K ﹤0.01%
2,100
+1,300
+163% +$9.22K
VXRT
12898
PUT
DELISTED
Vaxart
VXRT
$14.9K ﹤0.01%
20,400
+3,500
+21% +$3.25K
RTB
12899
RTB Digital
RTB
$237M
$14.9K ﹤0.01%
57
AMRX icon
12900
PUT
Amneal Pharmaceuticals
AMRX
$6.32B
$14.9K ﹤0.01%
4,800
-800
-14% -$1.7K

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.